DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Yau T, Kang Y-K, Kim T-Y. , et al.
Nivolumab (NIVO) + ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): results from CheckMate 040.
J Clin Oncol 2019;
37: 4012-4012
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.